Using 18F-Fluorodeoxyglucose Positron Emission Tomography to Estimate the Length of Gross Tumor in Patients With Squamous Cell Carcinoma of the Esophagus

This publication has 15 references indexed in Scilit:

• Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non–small-cell lung cancer
  International Journal of Radiation Oncology*Biology*Physics, 2007
• A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer
  Radiotherapy and Oncology, 2006
• Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography
  International Journal of Radiation Oncology*Biology*Physics, 2005
• F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer
  Head & Neck, 2005
• The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma
  International Journal of Radiation Oncology*Biology*Physics, 2005
• Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non–small-cell lung cancer: A modeling study
  International Journal of Radiation Oncology*Biology*Physics, 2005
• The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma
  Cancer, 2004
• Impact of FDG-PET on radiation therapy volume delineation in non–small-cell lung cancer
  International Journal of Radiation Oncology*Biology*Physics, 2004
• Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass Lesions
  JAMA, 2001
• The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer1
  Lung Cancer, 1998